Sign up to our newsletter Subscribe
Analysing Global Immunisation Expenditure
Combination Therapies
In some disease areas — primarily oncology — multiple medicines are used simultaneously or in short succession. These ‘Combination Therapies’ are a promising avenue for biomedical research but present economic challenges.
A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases
